589 related articles for article (PubMed ID: 21447010)
1. Nanomedicine in cancer therapy: innovative trends and prospects.
Blanco E; Hsiao A; Mann AP; Landry MG; Meric-Bernstam F; Ferrari M
Cancer Sci; 2011 Jul; 102(7):1247-52. PubMed ID: 21447010
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
[TBL] [Abstract][Full Text] [Related]
4. Emerging nanotherapeutic strategies in breast cancer.
Blanco E; Ferrari M
Breast; 2014 Feb; 23(1):10-8. PubMed ID: 24215984
[TBL] [Abstract][Full Text] [Related]
5. Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review.
Bhattacharjee H; Balabathula P; Wood GC
Ther Deliv; 2010 Nov; 1(5):713-34. PubMed ID: 22833959
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
7. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
Heneweer C; Gendy SE; Peñate-Medina O
Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
[TBL] [Abstract][Full Text] [Related]
8. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications.
Saadh MJ; Mustafa MA; Kumar A; Alamir HTA; Kumar A; Khudair SA; Faisal A; Alubiady MHS; Jalal SS; Shafik SS; Ahmad I; Khry FAF; Abosaoda MK
AAPS PharmSciTech; 2024 Jun; 25(6):140. PubMed ID: 38890191
[TBL] [Abstract][Full Text] [Related]
9. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
[TBL] [Abstract][Full Text] [Related]
10. Molecular-targeted nanotherapies in cancer: enabling treatment specificity.
Blanco E; Hsiao A; Ruiz-Esparza GU; Landry MG; Meric-Bernstam F; Ferrari M
Mol Oncol; 2011 Dec; 5(6):492-503. PubMed ID: 22071376
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine therapeutic approaches to overcome cancer drug resistance.
Markman JL; Rekechenetskiy A; Holler E; Ljubimova JY
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1866-79. PubMed ID: 24120656
[TBL] [Abstract][Full Text] [Related]
14. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
Cao J; Huang D; Peppas NA
Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
16. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
Wu KY; Wang XC; Anderson M; Tran SD
Molecules; 2024 May; 29(10):. PubMed ID: 38792122
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnological carriers for cancer chemotherapy: the state of the art.
Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
[TBL] [Abstract][Full Text] [Related]
20. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
